Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964–2003 followed up to the end of 2006

References

• Engholm G, Ferlay J, Christensen N, Bray F, Klint Å, Ólafsdóttir E, . NORDCAN: Cancer incidence, mortality and prevalence in the Nordic countries. Version 3.3. 2008. Available from: http://www.ancr.nu.
   Google Scholar
• IARC monographs on the evaluation of carcinogenic risks to humans. 55. Solar and ultraviolet radiation. Lyon: International Agency for Research on Cancer; 1992.
   Google Scholar
• Gruber SB, Armstrong BK. Cutaneous and ocular melanoma. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. New York: Oxford University Press; 2006. 1196–229.
   Google Scholar
• Birch-Johansen F, Hvilsom G, Kjaer T, Storm H. Social inequality and incidence of and survival from malignant melanoma in a population-based study in Denmark, 1994–2003. Eur J Cancer 2008;44:2043–9.
   PubMed Web of Science ®Google Scholar
• Aitchison TC, Sirel JM, Watt DC, MacKie RM (for the Scottish Melanoma Group). Prognostic trees to aid prognosis in patients with cutaneous malignant melanoma. BMJ 1995; 311(7019):1536–9.
   PubMedGoogle Scholar
• Karakousis CP, Driscoll DL. Prognostic parameters in localised melanoma: Gender versus anatomical location. Eur J Cancer 1995;31A:320–4.
   PubMedGoogle Scholar
• Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, . Gender-related differences in outcome for melanoma patients. Ann Surg 2006;243:693–8.
   PubMed Web of Science ®Google Scholar
• de Vries E, Nijsten TE, Visser O, Bastiaannet E, van Hattem S, Janssen-Heijnen ML, . Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. Ann Oncol 2008;19:583–9.
   PubMedGoogle Scholar
• Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R; EUROCARE Working Group. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 2009;45:931–91.
   PubMed Web of Science ®Google Scholar
• Engeland A, Haldorsen T, Tretli S, Hakulinen T, Hörte LG, Luostarinen T, . Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries. APMIS 1995;103(Suppl 49): 1–163.
   PubMedGoogle Scholar
• Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Material and methods. Acta Oncol 2010.
   Google Scholar
• Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307–16.
   PubMed Web of Science ®Google Scholar
• Balch CM, Soong SJ, Milton GW, Shaw HM, McGovern VJ, McCarthy WH, . Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia. Cancer 1983;52:1748–53.
   PubMedGoogle Scholar
• Garbe C, Eigentler TK. Diagnosis and treatment of cutaneous melanoma: State of the art 2006. Melanoma Res 2007;17:117–27.
   PubMed Web of Science ®Google Scholar
• Dummer R, Hauschild A, Pentheroudakis G. Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009;20 (Suppl 4):iv129–iv131.
   Google Scholar
• Lasithiotakis KG, Leiter U, Eigentler T, Breuninger H, Metzler G, Meier F, . Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976–2001: Which factors contributed? Cancer 2007;109:1174–82.
   PubMedGoogle Scholar
• Autier P, Boniol M, Héry C, Masuyer E, Ferlay J. Cancer survival statistics should be viewed with caution. Lancet Oncol 2007;8:1050–2.
   PubMedGoogle Scholar
• Lindholm C, Andersson R, Dufmats M, Hansson J, Ingvar C, Möller T, . Invasive cutaneous malignant melanoma in Sweden, 1990–1999. A prospective, population-based study of survival and prognostic factors. Cancer 2004;101: 2067–78.
   PubMedGoogle Scholar
• Ringborg U, Lagerlöf B, Broberg M, Månsson-Brahme E, Platz A, Thörn M. Early detection and prevention of cutaneous malignant melanoma: Emphasis on Swedish activities. Med Oncol Tumor Pharmacother 1991;8:183–7.
   PubMedGoogle Scholar
• Héry C, Tryggvadóttir L, Sigurdsson T, Ólafsdóttir E, Sigurgeirsson B, Jonasson JG, . A melanoma epidemic in Iceland: Possible influence of sunbed use. Am J Epidemiol 2010 (in press).
   PubMedGoogle Scholar
• Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. Br Med J 1996;312:1121–5.
   PubMed Web of Science ®Google Scholar
• Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: Evidence for contrasting trends between populations. Br J Cancer 2000;82:1887–91.
   PubMed Web of Science ®Google Scholar
• Precursors to malignant melanoma. National Institutes of Health Consensus Development Conference Statement, October 24–26, 1983. J Am Acad Dermatol 1984;10: 683–8.
   PubMedGoogle Scholar
• MacKie RM, Osterlind A, Ruiter D, Fritsch P, Aapro M, Cesarini JP, . Report on consensus meeting of the EORTC Melanoma Group on educational needs for primary and secondary prevention of melanoma in Europe. Results of a workshop held under the auspices of the EEC Europe against cancer programme in Innsbruck, April 1991. Eur J Cancer 1991;27:1317–23.
   PubMed Web of Science ®Google Scholar
• MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ 1992;304(6833):1012–5.
   PubMedGoogle Scholar